Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.

 
Web www.patentalert.com

< Specific mechanism for inhibiting platelet adhesion to collagen

> Trans-septal/trans-myocardial ventricular pacing lead

~ 00481